Apparently aimed a managing supply expectations as COVID-19 vaccine frontrunners move closer to key data readouts and potential emergency use authorizations, Moderna (MRNA -1.2%) discloses that it expects to produce ~20M doses of mRNA-1273 this year. Projections for next year, previously announced, are 500M – 1,000M doses.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.